Adam D. Cutler - 24 Jan 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Jan 2022, 15:17:00 UTC
Prior SEC filing
30 Dec 2021
Next SEC filing
15 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bruce Colwill, attorney-in-fact for Mr. Adam D. Cutler

Key filing fact

Adam D. Cutler filed Form 4 for InMed Pharmaceuticals Inc. (INM) on 24 Jan 2022.

Key facts

  • This page summarizes Adam D. Cutler's Form 4 filing for InMed Pharmaceuticals Inc. (INM).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 24 Jan 2022, 15:17.

Change

  • Previous filing in this sequence was filed on 30 Dec 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INM transaction Derivative

Employee Stock Option (Expiration)

Expiration (or cancellation) of long derivative position with value received

Transaction value
$0
Shares
-6,061
Change %
-13%
Price
$0.000000
Shares after
40,364
Date
24 Jan 2022
Ownership
Direct
Underlying class
Common shares
Underlying amount
6,061
Exercise price
$3.82
Footnotes
F1
INM transaction Derivative

Employee Stock Option (Expiration)

Expiration (or cancellation) of long derivative position with value received

Transaction value
$0
Shares
-1,515
Change %
-3.8%
Price
$0.000000
Shares after
38,849
Date
24 Jan 2022
Ownership
Direct
Underlying class
Common shares
Underlying amount
1,515
Exercise price
$3.68
Footnotes
F2
INM transaction Derivative

Employee Stock Option (Expiration)

Expiration (or cancellation) of long derivative position with value received

Transaction value
$0
Shares
-22,727
Change %
-59%
Price
$0.000000
Shares after
16,122
Date
24 Jan 2022
Ownership
Direct
Underlying class
Common shares
Underlying amount
22,727
Exercise price
$2.89
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Converted from the Canadian dollar exercise price of C$4.79 using an exchange rate of C$1.2554 = $US1.00

Footnote F2

Converted from the Canadian dollar exercise price of C$4.62 using an exchange rate of C$1.2554 = $US1.00

Footnote F3

Converted from the Canadian dollar exercise price of C$3.63 using an exchange rate of C$1.2554 = $US1.00

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .